首页> 美国卫生研究院文献>Theranostics >Label-Free Luminescent Mesoporous Silica Nanoparticles for Imaging and Drug Delivery
【2h】

Label-Free Luminescent Mesoporous Silica Nanoparticles for Imaging and Drug Delivery

机译:用于成像和药物输送的无标签发光中孔二氧化硅纳米粒子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report herein a straightforward and label-free approach to prepare luminescent mesoporous silica nanoparticles. We found that calcination at 400 °C can grant mesoporous organosilica nanoparticles with strong fluorescence of great photo- and chemical stability. The luminescence is found to originate from the carbon dots generated from the calcination, rather than the defects in the silica matrix as was believed previously. The calcination does not impact the particles' abilities to load drugs and conjugate to biomolecules. In a proof-of-concept study, we demonstrated that doxorubicin (Dox) can be efficiently encapsulated into these fluorescent mesoporous silica nanoparticles. After coupled to c(RGDyK), the nanoconjugates can efficiently home to tumors through interactions with integrin αvβ3 overexpressed on the tumor vasculature. This calcination-induced luminescence is expected to find wide applications in silica-based drug delivery, nanoparticle coating, and immunofluorescence imaging.
机译:我们在此报告了一种制备发光中孔二氧化硅纳米粒子的简单且无标签的方法。我们发现,在400°C下煅烧可以使介孔有机硅纳米粒子具有较强的荧光,并具有良好的光化学稳定性。发现发光来自煅烧产生的碳点,而不是先前认为的二氧化硅基质中的缺陷。煅烧不会影响颗粒负载药物和与生物分子结合的能力。在概念验证研究中,我们证明了阿霉素(Dox)可以有效地封装到这些荧光中孔二氧化硅纳米粒子中。与c(RGDyK)偶联后,纳米复合物可以通过与在肿瘤血管上过度表达的整联蛋白αvβ3的相互作用有效地归巢于肿瘤。预期这种煅烧诱导的发光将在基于二氧化硅的药物递送,纳米颗粒包衣和免疫荧光成像中找到广泛的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号